Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study

被引：9
|
作者：
Overcast, Wynton B. [1 ]
Zhang, Jianying [2 ]
Zynger, Debra L. [3 ]
Tozbikian, Gary H. [3 ]
机构：
[1] Ohio State Univ, Coll Med, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, 320 Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Wexner Med Ctr, 410 W 10th Ave,E410 Doan Hall, Columbus, OH 43210 USA
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷 / 02期
关键词：
ASCO/CAP guidelines; Breast cancer; Equivocal category; HER2 immunohistochemistry (IHC); HER2 fluorescence in situ hybridization (FISH); IN-SITU HYBRIDIZATION; POLYMERASE CHAIN-REACTION; CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; COPY NUMBER; CANCER; RECEPTOR; IMMUNOHISTOCHEMISTRY; TRASTUZUMAB; FISH;
D O I：
10.1007/s00428-016-1951-8
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
[No abstract available]
引用
收藏
页码：203 / 212
页数：10
相关论文
共 50 条
  • [1] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study
    Wynton B. Overcast
    Jianying Zhang
    Debra L. Zynger
    Gary H. Tozbikian
    Virchows Archiv, 2016, 469 : 203 - 212
  • [2] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results
    Zhang, Songlin
    Wang, Xiaohong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S144 - S144
  • [3] Evaluation of the Impact of the Updated ASCO/CAP 2018 HER2 Guidelines in Invasive Breast Carcinoma
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2019, 99
  • [4] Evaluation of the Impact of the Updated ASCO/CAP 2018 HER2 Guidelines in Invasive Breast Carcinoma
    Mehr, Chelsea
    Collins, Laura
    Quintana, Liza
    MODERN PATHOLOGY, 2019, 32
  • [5] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Zhi-Hua Liu
    Kun Wang
    Dan-Yi Lin
    Jie Xu
    Jie Chen
    Xiao-Yu Long
    Yan Ge
    Xin-Lan Luo
    Ke-Ping Zhang
    Yan-Hui Liu
    Fang-Ping Xu
    Breast Cancer Research and Treatment, 2019, 175 : 51 - 57
  • [6] Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases
    Liu, Zhi-Hua
    Wang, Kun
    Lin, Dan-Yi
    Xu, Jie
    Chen, Jie
    Long, Xiao-Yu
    Ge, Yan
    Luo, Xin-Lan
    Zhang, Ke-Ping
    Liu, Yan-Hui
    Xu, Fang-Ping
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (01) : 51 - 57
  • [7] Impact of modified 2013 ASCO/CAP guidelines on HER2 testing in breast cancer
    Varga, Z.
    Noske, A.
    BREAST, 2015, 24 : S108 - S108
  • [8] Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer
    Xu, Bin
    Shen, Jianguo
    Guo, Wenhao
    Zhao, Wenhe
    Zhuang, Yiyu
    Wang, Linbo
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (02) : 251 - 255
  • [9] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    LABORATORY INVESTIGATION, 2019, 99
  • [10] Impact of the 2018 ASCO/CAP HER2 Guideline Updates on HER2 Assessment in Breast Cancer with HER2 Immunohistochemistry Equivocal Results
    Wen, Hannah
    Ventura, Katia
    Xu, Jin
    Ross, Dara
    Dang, Chau
    Robson, Mark
    Norton, Larry
    Morrow, Monica
    Brogi, Edi
    MODERN PATHOLOGY, 2019, 32
12345